Cancer Driver Gene Detection with Gene-Specific Mutation Modeling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting cancer driver genes and pathways suffer from low concordance and high false positives/negatives due to the heterogeneity of mutational contexts in cancer cohorts, leading to inaccurate identification of genes and pathways involved in tumorigenesis.
Innovation Solution
A statistical model is used to determine gene-specific background mutation rates by optimizing parameters through negative binomial regression and Bayesian inference, accounting for both known and unknown influencing factors, to identify significantly mutated genes and pathways.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current methods (recurrent mutation, spatial pattern, functional impact bias) are used to detect driver genes, then driver gene identification is performed, but false positives and negatives increase due to low concordance across methods
Solution Approach 1:
The patent changes the fundamental parameter for driver detection from qualitative pattern recognition (recurrence, spatial clustering, functional impact) to quantitative statistical modeling using gene-specific background mutation rates. By calculating expected mutation counts based on gene length, replication timing, and other factors, the method transforms driver detection into a precise statistical comparison between observed and expected mutations, thereby improving both accuracy and reliability.
Solution Approach 2:
The patent replaces the mechanical/system-based approach of multiple detection algorithms with a statistical model-based system. Instead of using multiple heuristic methods that compete or complement each other, the invention uses a unified statistical framework that models background mutation processes and identifies drivers through deviation from expected patterns, substituting complex algorithmic systems with a more fundamental statistical approach.
2Measurement precision
If gene-specific background mutation rates are modeled using statistical methods, then detection accuracy improves, but computational complexity increases
Solution Approach 1:
The patent segments the complex task of driver detection into independent gene-level analyses. By calculating gene-specific background mutation rates separately for each gene (based on its length, replication timing, and other gene-specific factors), the method breaks down the genome-wide problem into manageable units that can be processed independently, reducing overall computational complexity while maintaining high precision.
Solution Approach 2:
The patent uses copying by creating a virtual model of expected background mutations for each gene based on established biological parameters. Instead of analyzing every possible mutation pattern directly, the method copies the expected behavior of background mutations (using gene length, replication timing, and other factors) and compares observed mutations against this copied expectation, simplifying the analysis while improving accuracy.
Data Source
AI summary
Described herein are methods, systems, and apparatuses for detecting significantly mutated genes/pathways in a cancer cohort. A driver gene detection technique taking into account the heterogeneous mutational context in a cancer cohort is disclosed. A statistical model of a gene-specific mutation rate distribution (e.g., using an optimized gene specific mean estimation and/or a gene-specific dispersion estimation) is used to model a sample/gene-specific background mutation rate. The statistical model may then be used to detect gene/pathway enrichment and distinguish tumor suppressors and oncogenes based on the spatial distribution of non-silent mutations, loss-of-function mutations, and/or gain-of-function mutations.